Cargando…
Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis
Sunitinib is one of the first‐line targeted drugs for metastatic renal cell carcinoma (RCC) with dual effects of antiangiogensis and proapoptosis. Sam68 (Src‐associated in mitosis, 68 KDa), is found being involved in cell apoptosis. This article reveals that Sam68 impacts the sensitivity to sunitini...
Autores principales: | Wu, Zeshen, Peng, Yulu, Xiong, Longbin, Wang, Jun, Li, Zhen, Ning, Kang, Deng, Minhua, Wang, Ning, Wei, Wensu, Li, Zhiyong, Dong, Pei, Yu, Chunping, Zhou, Fangjian, Zhang, Zhiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554455/ https://www.ncbi.nlm.nih.gov/pubmed/35476809 http://dx.doi.org/10.1002/cam4.4743 |
Ejemplares similares
-
FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA
por: Deng, Minhua, et al.
Publicado: (2022) -
Utility of SAM68 in the progression and prognosis for bladder cancer
por: Zhang, Zhiling, et al.
Publicado: (2015) -
Immune checkpoint inhibitors further aggravate proteinuria in patients with metastatic renal cell carcinoma after long-term targeted therapy
por: Ning, Kang, et al.
Publicado: (2022) -
Nkx2.8 promotes chemosensitivity in bladder urothelial carcinoma via transcriptional repression of MDR1
por: Zhou, Zhaohui, et al.
Publicado: (2022) -
Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma
por: Zhang, Zhiling, et al.
Publicado: (2021)